Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug1533 | Equipment with smartwatch throughout hospital stay on the general ward Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D012141 | Respiratory Tract Infections NIH | 0.15 |
D003141 | Communicable Diseases NIH | 0.07 |
D007239 | Infection NIH | 0.05 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0011947 | Respiratory tract infection HPO | 0.15 |
Navigate: Correlations HPO
There is one clinical trial.
Respiratory infections, including episodes of coughing with fever, are the main cause of outpatient antibiotic prescription, while a minority of them are linked to bacterial infections requiring antibiotic. These prescriptions are often performed by general practitioners. These unnecessary antibiotic contribute to increased bacterial resistance, side effects and unnecessary costs. Campaigns for the correct prescription of antibiotics have had a real but partial or transient success. C-reactive protein micro-method (POCT-CRP) could help to differentiate between viral and bacterial infections and thus contribute to the proper use of antibiotics. The decrease in prescription of antibiotics is likely to have an even stronger positive impact in countries like France, where prescription is high. The objective of this study is to evaluate the use of POCT-CRP in the general practitioner's office in case of suspected respiratory infection.
Description: with and without POCT-CRP
Measure: Frequency of antibiotic therapy prescribed Time: 10 daysDescription: with and without POCT-CRP
Measure: Frequency of antibiotic therapy prescribed in patients aged from 3 to 17 years old Time: 10 daysDescription: with and without POCT-CRP
Measure: Frequency of antibiotic therapy prescribed in patients aged from 18 to 64 years old Time: 10 daysDescription: with and without POCT-CRP
Measure: Frequency of antibiotic therapy prescribed in patients older than 65 years old Time: 10 daysDescription: with and without POCT-CRP
Measure: Frequency of complementary exam Time: 10 daysDescription: with and without POCT-CRP
Measure: type of complementary exam Time: 10 daysDescription: with and without POCT-CRP
Measure: Proportion of number of patients referred to emergency Time: 10 daysDescription: with and without POCT-CRP
Measure: Proportion of number of patients with delayed antibiotic therapy Time: 10 daysDescription: Adequacy between the proposed decision algorithm according to the C-reactive protein assay and the antibiotic prescription
Measure: number of prescription following the recommended algorythms Time: 10 daysDescription: The assessment of the utility of the POCT procedure
Measure: Concordance between the prescription proposed by the decision algorithm as a function of the micro-CRP and the prescription realized: kappa coefficient Time: 10 daysDescription: Number of COVID-19 positive patients by diagnostic method (From October 2020)
Measure: COVID-19 positive patients Time: 20 minutesAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports